EAU 2018

EAU 2018: Clinicopathologic Factors Linked to Intravesical Recurrence after Radical Nephroureterectomy to Treat Upper Tract Urothelial Carcinoma

Copenhagen, Denmark (UroToday.com)  Dr. Seisen proided a talk which focused on the clinicopathology factors linked to intravesical recurrence (IVR) following radical nephroureterectomy (RNU) to treat upper tract urothelial carcinoma. His talk was primarily based on the recent systematic review that he spearheaded (Seisen et al, European Urology, 2014). This has since been translated into the guidelines for the EAU.

EAU 2018: Can we Rely on Urinary Markers?

Copenhagen, Denmark (UroToday.com)  Dr. Shariat was tasked with addressing the role of urinary markers for UTUC. The short answer is … no. However, there is a lot of potential for urinary markers, and he provided a summary of the current landscape.

EAU 2018: Instillations in The Upper Tract: Which Technique?

Copenhagen, Denmark (UroToday.com) Dr. Seiler presented a summary of upper tract instillations and a discussion of the best method to utilize. 

EAU 2018: Challenges in Prevention of Bladder Recurrence

Copenhagen, Denmark (UroToday.com) Dr. Baard presented a talk on bladder recurrence and how to prevent it in patients with upper tract urothelial cancer (UTUC). UTUC and bladder involvement:

EAU 2018: Now or Never - Realizing the Promise of Precision Oncology for Urothelial Carcinoma

Copenhagen, Denmark (UroToday.com) Dr. Black gave a talk on the promise of precision oncology for urothelial carcinoma. Precision oncology allows to personalize treatment for patients and improve their outcomes. The precision oncology workflow is described in Figure 1, starting from tissue biopsy, and going through biomarkers, target identification, validation, drug selection, and monitoring for relapse. 

EAU 2018: Does New Molecular Subtyping in Urothelial Cancer Add to Tumor, Nodes and Metastasis

Copenhagen, Denmark (UroToday.com) Dr. Comperat, gave an overview of the potential benefit of adding molecular subtyping to standard pathological analysis.

EAU 2018: Urogenital Tuberculosis: The Cause Of Ineffective Antibacterial Therapy For Urinary Tract Infections

Copenhagen, Denmark (UroToday.com) Dr. Kulchavenya, a clinical urologist from the Novosibirsk Research TB Institute, Novosibirsk Medical University, Dept. of Urology, presented on antibiotic resistance and bacterial strain similarities found in those diagnosed with a long history of urinary tract infection (UTI) and suspicious for urogenital tuberculosis (UGBT). UGTB has no specific symptoms, therefore there are currently no screening methods for early detection. However, UTIs are considered first line for differential diagnosis with UGTB.